prospect of new therapies for aml
Published 7 years ago • 100 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:19
new treatments for aml
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
2:38
session highlights: transforming aml treatment and building on new approaches
-
1:36
targeted therapy for aml
-
4:46
acute myeloid leukemia (aml) treatment options
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
14:43
current research into post-allosct maintenance therapy in aml
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
1:17
combination therapy for the treatment of aml
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
3:37
the future of aml treatment
-
1:54
new developments in aml treatment
-
1:23
new treatments for aml using inhibitors
-
1:42
novel treatment combinations in aml: what’s to come?
-
3:47
the role of immunotherapy in the aml treatment landscape
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
2:34
the evolution of the aml treatment paradigm
-
5:11
the frontline treatment strategy for newly diagnosed aml